Meridian Bioscience Inc: Device Recall
Recall #Z-1019-2026 · 12/05/2025
Class II: Risk
Recall Details
- Recall Number
- Z-1019-2026
- Classification
- Class II
- Product Type
- Device
- Recalling Firm
- Meridian Bioscience Inc
- Status
- Ongoing
- Date Initiated
- 12/05/2025
- Location
- Cincinnati, OH, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 211 units
Reason for Recall
The affected lots show a decline in performance over time, which may lead to false-negative results.
Product Description
Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300
Distribution Pattern
US Nationwide distribution and the OUS country of Italy.
Other Recalls by Meridian Bioscience Inc
- Class II: Risk 10/07/2025
- Class II: Risk 10/07/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.